198699943	198699943	CD	B-NP	O
|	|	NN	I-NP	O
IEM	IEM	NN	I-NP	O
|	|	NN	I-NP	O
95549472	95549472	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9501498	9501498	CD	B-NP	O
|	|	CC	I-NP	O
7/28/2006	7/28/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
STEMI	STEMI	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/16/2006	1/16/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/10/2006	10/10/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
DELGENIO	DELGENIO	NN	B-NP	O
,	,	,	O	O
LEON	LEON	NN	B-NP	O
640-66-11-8	640-66-11-8	CD	I-NP	O
T97	T97	NN	I-NP	O
Room	Room	NNP	I-NP	O
:	:	:	O	O
40Y-282	40Y-282	NNP	B-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
7/10/06	7/10/06	CD	B-NP	O
AT	AT	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SPEIDEN	SPEIDEN	NNP	B-NP	O
,	,	,	O	O
ELTON	ELTON	NNP	B-NP	O
SAMMY	SAMMY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DISPOSITION	DISPOSITION	NNP	I-NP	O
:	:	:	O	O
Home	Home	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
LIPITOR	LIPITOR	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/16/06	10/16/06	CD	B-NP	O
by	by	IN	B-PP	O
ZOLINSKI	ZOLINSKI	NN	B-NP	O
,	,	,	O	O
CHRISTOPER	CHRISTOPER	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
MULTIVITAMIN	MULTIVITAMIN	NN	B-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
892003049	892003049	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
mda	mda	NN	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/12/06	11/12/06	CD	B-NP	O
by	by	IN	B-PP	O
CEPPETELLI	CEPPETELLI	NNP	B-NP	O
,	,	,	O	O
EMILIO	EMILIO	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LIPITOR	LIPITOR	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
481415718	481415718	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
DEFINITE	DEFINITE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
ATORVASTATIN	ATORVASTATIN	NN	B-NP	B-protein
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Unknown	Unknown	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
not	not	RB	B-NP	O
allergic	allergic	JJ	I-NP	O
PLAVIX	PLAVIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
-RRB-	-RRB-	HYPH	O	O
75	75	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Tomorrow	Tomorrow	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
6/16	6/16	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/16/06	10/16/06	CD	B-NP	O
by	by	IN	B-PP	O
DANNENBERG	DANNENBERG	NNP	B-NP	O
,	,	,	O	O
LOUIE	LOUIE	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
IBUPROFEN	IBUPROFEN	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
768866646	768866646	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CLOPIDOGREL	CLOPIDOGREL	NNP	B-NP	O
BISULFATE	BISULFATE	NNP	I-NP	O
&	&	CC	I-NP	O
IBUPROFEN	IBUPROFEN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	VB	B-VP	O
ENTERIC	ENTERIC	NNP	B-NP	O
COATED	COATED	NNP	I-NP	O
ASA	ASA	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	B-NP	O
100	100	CD	B-NP	O
or	or	CC	O	O
hr	hr	NN	B-NP	O
<	<	SYM	O	O
55	55	CD	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
7/10/06	7/10/06	CD	B-NP	O
by	by	IN	B-PP	O
GILLIARD	GILLIARD	NNP	B-NP	O
,	,	,	O	O
RANDY	RANDY	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	VB	B-VP	O
TOPROL	TOPROL	NNP	B-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
NITROGLYCERIN	NITROGLYCERIN	NN	I-NP	O
1/150	1/150	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
0.4	0.4	CD	I-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-DNA
SL	SL	NN	I-NP	I-DNA
Q5MIN	Q5MIN	NN	I-NP	I-DNA
X	X	NN	I-NP	I-DNA
3	3	CD	I-NP	I-DNA
doses	dose	VBZ	B-VP	O
PRN	PRN	NNP	B-NP	O
Pain	Pain	NNP	I-NP	O
DIET	DIET	NNP	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
RETURN	RETURN	NNP	I-NP	O
TO	TO	NNP	I-NP	O
WORK	WORK	NNP	I-NP	O
:	:	:	O	O
Not	Not	NNP	B-NP	O
Applicable	Applicable	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Walker	Walker	NNP	I-NP	O
Porras	Porras	NNP	I-NP	O
call	call	NN	I-NP	O
office	office	NN	I-NP	O
for	for	IN	B-PP	O
appointment	appointment	NN	B-NP	O
,	,	,	O	O
No	No	NNP	B-NP	O
Known	Known	NNP	I-NP	O
Allergies	Allergies	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
ST	ST	JJ	B-NP	O
elevation	elevation	NN	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
STEMI	STEMI	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
ST	ST	NNP	I-NP	O
elevation	elevation	NN	I-NP	O
MI	MI	NN	I-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
smoker	smoker	NN	I-NP	O
etoh	etoh	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
Catherization	Catherization	NN	B-NP	O
:	:	:	O	O
L	L	NN	B-NP	O
coronaries	coronary	NNS	I-NP	O
clean	clean	JJ	B-ADJP	O
.	.	.	O	O

100	100	CD	B-NP	O
%	%	NN	I-NP	O
ostial	ostial	JJ	I-NP	O
RCA	RCA	NN	I-NP	O
thrombotic	thrombotic	JJ	I-NP	O
lesion	lesion	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
stented	stente	VBN	I-VP	O
to	to	TO	B-PP	O
0	0	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
TIMI	TIMI	NN	B-NP	B-protein
flow	flow	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Reason	Reason	NNP	B-NP	O
for	for	IN	B-PP	O
Admit	Admit	NNP	B-NP	O
:	:	:	O	O
transfer	transfer	VB	B-VP	O
from	from	IN	B-PP	O
A	A	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
for	for	IN	B-PP	O
STEMI	STEMI	NN	B-NP	B-protein
and	and	CC	O	O
urgent	urgent	JJ	B-NP	O
catherization	catherization	NN	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
Mr.	Mr.	NNP	B-NP	O
Hegarty	Hegarty	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
47M	47M	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
h/o	h/o	NN	I-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
active	active	JJ	B-NP	O
smoking	smoking	NN	I-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
alcohol	alcohol	NN	I-NP	O
use	use	NN	I-NP	O
and	and	CC	O	O
uncontrolled	uncontrolled	JJ	B-NP	O
dyslipidemia	dyslipidemia	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
UISH	UISH	NN	B-NP	O
after	after	IN	B-PP	O
2	2	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
substernal	substernal	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
radiating	radiate	VBG	B-VP	O
to	to	TO	B-PP	O
neck	neck	NN	B-NP	O
and	and	CC	I-NP	O
L	L	NN	I-NP	O
arm	arm	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
late	late	JJ	I-NP	O
afternoon	afternoon	NN	I-NP	O
of	of	IN	B-PP	O
8/24	8/24	CD	B-NP	O
At	At	IN	B-PP	O
the	the	DT	B-NP	O
NMAC	NMAC	NN	I-NP	B-protein
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
transient	transient	JJ	B-NP	O
STEMI	STEMI	NN	I-NP	O
note	note	NN	I-NP	O
at	at	IN	B-PP	O
2am	2am	NN	B-NP	O
with	with	IN	B-PP	O
initial	initial	JJ	B-NP	O
troponin	troponin	NN	I-NP	O
of	of	IN	B-PP	O
0.06	0.06	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
asa	asa	NN	B-NP	O
,	,	,	O	O
heparin	heparin	NN	B-NP	O
,	,	,	O	O
plavix	plavix	NN	B-NP	B-protein
loaded	load	VBD	B-VP	I-protein
-LRB-	-LRB-	SYM	B-NP	I-protein
300	300	CD	B-NP	I-protein
mg	mg	NN	I-NP	I-protein
x	x	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
morphine	morphine	NN	B-NP	O
and	and	CC	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
WHAMC	WHAMC	NNP	B-NP	O
for	for	IN	B-PP	O
urgent	urgent	JJ	B-NP	O
catherization	catherization	NN	I-NP	O
.	.	.	O	O

Cath	Cath	NNP	B-NP	O
showed	show	VBD	B-VP	O
clean	clean	JJ	B-NP	O
left	left	JJ	I-NP	O
side	side	NN	I-NP	O
,	,	,	O	O
ostial	ostial	JJ	B-NP	O
RCA	RCA	NN	I-NP	O
thromus	thromus	NN	I-NP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
PTCA	PTCA	NN	B-NP	O
and	and	CC	O	O
stented	stente	VBD	B-VP	O
successful	successful	JJ	B-ADJP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
TIMI	TIMI	NN	I-NP	O
flow	flow	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
transient	transient	JJ	B-NP	O
post	post	NN	I-NP	O
procedure	procedure	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
ECG	ECG	NN	I-NP	O
changes	change	NNS	I-NP	O
relieved	relieve	VBN	B-VP	O
with	with	IN	B-PP	O
oxycodone	oxycodone	NN	B-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
difficulty	difficulty	NN	B-NP	O
laying	lay	VBG	B-VP	O
flat	flat	JJ	B-NP	O
,	,	,	I-NP	O
fem	fem	JJ	I-NP	O
stop	stop	NN	I-NP	O
temporarily	temporarily	RB	B-VP	O
placed	place	VBN	I-VP	O
.	.	.	O	O

--	--	:	O	O
--	--	:	O	O
-	-	HYPH	B-NP	O
Home	Home	NN	I-NP	O
meds	med	NNS	I-NP	O
:	:	:	O	O
lipitor	lipitor	NN	B-NP	O
20	20	CD	I-NP	O
,	,	,	O	O
not	not	RB	O	O
taking	take	VBG	B-VP	O
regularly	regularly	RB	B-ADVP	O
--	--	:	O	O
--	--	:	O	O
-	-	:	O	O
Status	Status	NN	B-NP	O
:	:	:	O	O
afebrile	afebrile	JJ	B-NP	O
hr	hr	NN	I-NP	O
72	72	CD	I-NP	O
,	,	,	O	O
bp	bp	NN	B-NP	O
124/82	124/82	CD	I-NP	O
,	,	,	O	O
18	18	CD	B-NP	O
96RA	96RA	NN	I-NP	O
.	.	.	O	O

NAD	NAD	NN	B-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

no	no	DT	B-NP	O
m/g	m/g	NN	I-NP	O
.	.	.	O	O

Moderate	Moderate	JJ	B-NP	O
size	size	NN	I-NP	O
groin	groin	NN	I-NP	O
ecchymosis	ecchymosis	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
hematoma	hematoma	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
bruit	bruit	NN	I-NP	O
.	.	.	O	O

--	--	:	O	O
Studies	Study	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

CXR	CXR	NN	B-NP	B-protein
:	:	:	O	O
LLL	LLL	NN	B-NP	B-protein
atelectasis	atelectasis	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

CUS	CUS	NNS	B-NP	O
:	:	:	O	O
L	L	NN	B-NP	O
clean	clean	NN	I-NP	O
.	.	.	O	O

R	R	NN	B-NP	O
prox	prox	NN	I-NP	O
and	and	CC	O	O
mid	mid	JJ	B-NP	O
ICA	ICA	NN	I-NP	O
0-25	0-25	CD	B-NP	O
%	%	NN	I-NP	O
;	;	:	O	O
25-49	25-49	CD	B-NP	O
%	%	NN	I-NP	O
plaque	plaque	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

AAA	AAA	NN	B-NP	O
CT	CT	NN	I-NP	O
:	:	:	O	O
prelim	prelim	VB	B-VP	O
read	read	VBN	I-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
aneurysm	aneurysm	NN	B-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Echo	Echo	NNP	B-NP	O
:	:	:	O	O
EF	EF	NN	B-NP	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
regional	regional	JJ	I-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
--	--	:	O	O
Impression	Impression	NN	B-NP	O
:	:	:	O	O
Inferior	Inferior	JJ	B-NP	O
STEMI	STEMI	NN	I-NP	O
s/p	s/p	NN	I-NP	O
rca	rca	NN	I-NP	O
stent	stent	JJ	I-NP	O
Plan	Plan	NN	I-NP	O
:	:	:	O	O
CV	CV	NN	B-NP	O
:	:	:	O	O
Troponin	Troponin	NN	B-NP	O
peak	peak	NN	I-NP	O
to	to	TO	B-PP	O
6	6	CD	B-NP	O
at	at	IN	B-PP	O
7pm	7pm	CD	B-NP	O
24	24	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
event	event	NN	B-NP	O
.	.	.	O	O

Received	Receive	VBN	B-NP	O
infliximab	infliximab	NN	I-NP	O
x	x	SYM	B-NP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

Discharged	Discharge	VBN	B-VP	O
on	on	IN	B-PP	O
asa	asa	NN	B-NP	O
325	325	CD	I-NP	O
for	for	IN	B-PP	O
life	life	NN	B-NP	O
,	,	,	O	O
plavix	plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
x	x	SYM	B-VP	O
30	30	CD	B-NP	O
days	day	NNS	I-NP	O
minimal	minimal	JJ	B-ADJP	O
,	,	,	O	O
toprol	toprol	NN	B-NP	B-protein
100	100	CD	I-NP	I-protein
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
5	5	CD	I-NP	O
,	,	,	O	O
lipitor	lipitor	NN	B-NP	O
80	80	CD	I-NP	O
-LRB-	-LRB-	:	O	O
LDL	LDL	NN	B-NP	B-protein
119	119	CD	I-NP	I-protein
at	at	IN	B-PP	O
admission	admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
time	time	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
euvolemic	euvolemic	JJ	I-NP	O
,	,	,	I-NP	O
sinus	sinus	JJ	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

ECG	ECG	NN	B-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
:	:	:	O	O
q	q	NN	B-NP	O
waves	wave	VBZ	B-VP	O
inferiorly	inferiorly	RB	B-ADVP	O
with	with	IN	B-PP	O
TWI	TWI	NN	B-NP	O
in	in	IN	B-PP	O
III	III	CD	B-NP	O
,	,	,	O	O
AFL	AFL	NNP	B-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
f/u	f/u	VB	I-VP	O
with	with	IN	B-PP	O
outpatient	outpatient	JJ	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
and	and	CC	I-NP	O
cardiology	cardiology	NN	I-NP	O
.	.	.	O	O

Provided	Provide	VBN	B-NP	O
smoking	smoking	NN	I-NP	O
cessation	cessation	NN	I-NP	O
and	and	CC	I-NP	O
alcohol	alcohol	NN	I-NP	O
counseling	counseling	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
concerned	concern	VBD	B-VP	O
about	about	IN	B-PP	O
impotence	impotence	NN	B-NP	O
while	while	IN	B-SBAR	O
taking	take	VBG	B-VP	O
betablocker	betablocker	NN	B-NP	O
,	,	,	O	O
instructed	instruct	VBN	B-VP	O
on	on	IN	B-PP	O
importance	importance	NN	B-NP	O
of	of	IN	B-PP	O
bb	bb	NN	B-NP	O
in	in	IN	B-PP	O
improving	improve	VBG	B-VP	O
morbidity	morbidity	NN	B-NP	O
and	and	CC	I-NP	O
mortality	mortality	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
to	to	TO	B-VP	O
f/u	f/u	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Lippe	Lippe	NNP	I-NP	O
at	at	IN	B-PP	O
LMCO	LMCO	NNP	B-NP	O
and	and	CC	O	O
Dr.	Dr.	NNP	B-NP	O
Mcmonagle	Mcmonagle	NNP	I-NP	O
PCP	PCP	NNP	I-NP	O
SMC	SMC	NNP	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
CILFONE	CILFONE	NNP	B-NP	O
,	,	,	O	O
CLINTON	CLINTON	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DA786	DA786	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7/10/06	7/10/06	CD	I-NP	O
@	@	SYM	B-NP	O
11	11	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

